NCT04893174View on ClinicalTrials.gov

Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).

PHASE1UnknownINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 15, 2022

Primary Completion Date

September 30, 2024

Study Completion Date

June 30, 2025

Conditions
Osteoarthritis, Knee
Interventions
BIOLOGICAL

UMC119-06-05

"Subjects will receive a single-dose IA injection of UMC119-06-05 followed by an IA injection of hyaluronic acid.~Cohort 1: Low does UMC119-06-05 Cohort 2: High does UMC119-06-05"

DEVICE

Hyaluronic acid

IA injection of hyaluronic acid.

Trial Locations (1)

110301

RECRUITING

Taipei Medical University Hospital, Taipei

Sponsors
All Listed Sponsors
lead

Meridigen Biotech Co., Ltd.

INDUSTRY

NCT04893174 - Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA). | Biotech Hunter | Biotech Hunter